This is an archive of papers published by the staff and faculty of Fox Chase Cancer Center. For questions about content, please contact Talbot Research Library
Last updated on
Li PD , Hu JL , Ma C , Ma H , Yao J , Chen LL , Chen J , Cheng TT , Yang KY , Wu G , Zhang WJ , Cao RB
Upregulation of the long non-coding RNA PVT1 promotes esophageal squamous cell carcinoma progression by acting as a molecular sponge of miR-203 and LASP1
Oncotarget. 2017 May 23;8(21) :34164-34176
PMID: 28404954 PMCID: PMC5470958 URL: https://www.ncbi.nlm.nih.gov/pubmed/28404954
AbstractLong non-coding RNAs are a group of non-coding RNAs longer than 200 nucleotides and possess diverse functions and exhibit exquisite cell-specific and developmental dynamic expression patterns. The role of the long non-coding RNA PVT1 in esophageal squamous cell carcinoma remains unsolved. Here, we showed that PVT1 expression is significantly up-regulated in ESCC tumor samples compared with their normal counterparts. Knockdown of PVT1 suppressed tumor growth in vitro and in vivo. Further studies revealed that silence of PVT1 lead to up-regulation of miR-203, and vice versa. Moreover, LASP1 was found to be downregulated after knockdown of PVT1 and overexpression of LASP1 attenuated the tumor-suppressive roles of PVT1 knockdown. Our results suggest that PVT1 promote ESCC progression via functioning as a molecular sponge for miR-203 and LASP1 and provide the first evidence of dysregulated PVT1/miR-203/LASP1 axis in ESCC.
Notes1949-2553 Li, Pin-Dong Hu, Jian-Li Ma, Charlie Ma, Hong Yao, Jing Chen, Li-Li Chen, Jing Cheng, Tian-Tian Yang, Kun-Yu Wu, Gang Zhang, Wen-Jie Cao, Ru-Bo Journal Article United States Oncotarget. 2017 Mar 3. doi: 10.18632/oncotarget.15878.